Gerald L. Ray & Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,999
Closed -$1.07M 330
2017
Q1
$1.07M Hold
11,999
0.15% 137
2016
Q4
$849K Hold
11,999
0.12% 151
2016
Q3
$948K Hold
11,999
0.14% 139
2016
Q2
$1.09M Hold
11,999
0.17% 117
2016
Q1
$1.02M Hold
11,999
0.17% 113
2015
Q4
$947K Sell
11,999
-125
-1% -$9.85K 0.15% 119
2015
Q3
$854K Hold
12,124
0.14% 131
2015
Q2
$1.09M Hold
12,124
0.17% 126
2015
Q1
$1.22M Hold
12,124
0.18% 116
2014
Q4
$1.22M Hold
12,124
0.19% 111
2014
Q3
$1.17M Hold
12,124
0.19% 112
2014
Q2
$1.13M Hold
12,124
0.19% 113
2014
Q1
$1.01M Hold
12,124
0.18% 119
2013
Q4
$1.01M Buy
12,124
+408
+3% +$33.2K 0.19% 115
2013
Q3
$870K Hold
11,716
0.18% 118
2013
Q2
$928K Buy
+11,716
New +$939K 0.21% 105

Other funds holding MJN

Gerald L. Ray & Associates's MJN Position: Q2 2017 in Review

Gerald L. Ray & Associates sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 11,999 shares — an estimated $1.07M sold.

Gerald L. Ray & Associates first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $1.22M in Q4 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Gerald L. Ray & Associates reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Gerald L. Ray & Associates sold 11,999 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.07M.
  • Gerald L. Ray & Associates first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Gerald L. Ray & Associates's Mead Johnson Nutrition Company position peaked at $1.22M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2017, filed 8 Aug 2017.